A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations.
Karelis G, Balasa R, De Bleecker JL, Stuchevskaya T, Villa A, Van Damme P, Lagrange E, Heckmann JM, Nicolle M, Vilciu C, Bril V, Mondou E, Griffin R, Chen J, Henriquez W, Garcia B, Camprubi S, Ayguasanosa J.
Karelis G, et al. Among authors: camprubi s.
Eur Neurol. 2019;81(5-6):223-230. doi: 10.1159/000502818. Epub 2019 Oct 25.
Eur Neurol. 2019.
PMID: 31655810
Free article.
Clinical Trial.